The Healthtech Times is a weekly newsletter covering healthtech news from Canada and around the globe. Subscribe to H|T using the form at the bottom of this page to ensure you don’t miss out on the most important healthtech news every week!
The project is valued at $25 million and will see participation from public and private backers.
Silicon Valley is obsessed with growth. And for digital health startups, that obsession is not only misguided, but dangerous.
Nurx adds STI testing to its mail-order product suite(MOBIHEALTHNEWS)
The startup launched three new test kits, which will test for conditions such as chlamydia, gonorrhea and syphilis.
Kencko develops plant-based products that help people eat healthily without having to suffer the pain of horrible-tasting food or other extreme eating.
Minneapolis athlete-safety startup raises $2 million(BIZJOURNALS)
Minneapolis-based Player’s Health has closed on a $2 million Series A round.
Lyon-based biotech startup Osivax raises €8 million to develop novel, universal flu vaccines(EUSTARTUPS)
Lyon–based biotech startup Osivax was founded in 2017 to develop a universal flu vaccine that will be effective year after year, despite mutations of the virus.
Doctours, a Los Angeles-based online platform for booking trips and treatments for medical and dental care around the world, is expanding its services to 35 countries.
Seattle biotech startup OncoSenX has reeled in $3 million to advance its pipeline of therapeutics that aim to kill cancer cells based on their genetics.
3iOntario Digest presents a list of ongoing funding opportunities and other resources to accelerate health innovation.
CAN – UK-Canada Diabetes Research Team Grants (read more)
CAN – Alliance Grants (read more)